Characterization of novel cell lines derived from a MYC-driven murine model of lethal metastatic adenocarcinoma of the prostate.
Mark C MarkowskiGretchen K HubbardJessica L HicksQizhi ZhengAlexia KingDavid EsopiApurv RegeSrinivasan YegnasubramanianCharles J BieberichAngelo M De MarzoPublished in: The Prostate (2018)
These cell lines are a novel model of androgen-insensitive prostatic adenocarcinoma driven by MYC over-expression and Pten loss.